Evidence map›Paper›PMID 32250715›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer.

Alyssa N Troeschel, Terryl J Hartman, Eric J Jacobs, Victoria L Stevens, Ted Gansler, W Dana Flanders, Lauren E McCullough, Ying Wang

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Association between body mass index and physical activity among prostate cancer survivors.Journal of cancer survivorship : research and practice · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alyssa N TroeschelDepartment of Epidemiology, Rollins School of Public Health and the Laney Graduate School, Emory University, Atlanta, GA.
Terryl J HartmanDepartment of Epidemiology, Rollins School of Public Health and the Laney Graduate School, Emory University, Atlanta, GA.
Eric J JacobsBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.
Victoria L StevensBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.
Ted GanslerBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.
W Dana FlandersDepartment of Epidemiology, Rollins School of Public Health and the Laney Graduate School, Emory University, Atlanta, GA.
Lauren E McCulloughDepartment of Epidemiology, Rollins School of Public Health and the Laney Graduate School, Emory University, Atlanta, GA.
Ying WangBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.
American Cancer Society · USEmory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the association of postdiagnosis body mass index (BMI) and weight change with prostate cancer-specific mortality (PCSM), cardiovascular disease-related mortality (CVDM), and all-cause mortality among survivors of nonmetastatic prostate cancer.

methodsMen in the Cancer Prevention Study II Nutrition Cohort diagnosed with nonmetastatic prostate cancer between 1992 and 2013 were followed for mortality through December 2016. Current weight was self-reported on follow-up questionnaires approximately every 2 years. Postdiagnosis BMI was obtained from the first survey completed 1 to < 6 years after diagnosis. Weight change was the difference in weight between the first and second postdiagnosis surveys. Deaths occurring within 4 years of the follow-up were excluded to reduce bias from reverse causation. Analyses of BMI and weight change included 8,330 and 6,942 participants, respectively.

resultsPostdiagnosis BMI analyses included 3,855 deaths from all causes (PCSM, n = 500; CVDM, n = 1,155). Using Cox proportional hazards models, hazard ratios (HRs) associated with postdiagnosis obesity (BMI ≥ 30 kg/m

conclusionResults suggest that among survivors of nonmetastatic prostate cancer with largely localized disease, postdiagnosis obesity is associated with higher CVDM and all-cause mortality, and possibly higher PCSM, and that postdiagnosis weight gain may be associated with a higher mortality as a result of all causes and prostate cancer.

Indexed as

Body Mass IndexBody WeightCancer SurvivorsAdultAgedAged, 80 and overCardiovascular DiseasesHumansMaleMiddle AgedProportional Hazards ModelsProstatic Neoplasms

Identifiers

PMID32250715
PMCPMC8265380
OpenAlexW3014616160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.